AFib is predicted to affect 6-12 million people in the USA and 17.9 million in Europe by 2050 and 2060, respectively. The global aging of the population is a significant factor contributing to the increase in AFib prevalence. Between 1990 and 2013, the overall number of AFib cases increased, despite a slight decrease in the global prevalence rate. AFib is associated with an increase in morbidity, as measured by disability-adjusted life years (DALYs).
Increase in AFib Cases
The global aging of the population is a significant factor contributing to the increase in AFib prevalence. Between 1990 and 2013, the overall number of AFib cases increased, despite a slight decrease in the global prevalence rate.
Impact on Morbidity
AFib is associated with an increase in morbidity, as measured by disability-adjusted life years (DALYs).